BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 9833996)

  • 1. Enhanced encapsulation of amphotericin B into liposomes by complex formation with polyethylene glycol derivatives.
    Moribe K; Tanaka E; Maruyama K; Iwatsuru M
    Pharm Res; 1998 Nov; 15(11):1737-42. PubMed ID: 9833996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Encapsulation characteristics of nystatin in liposomes: effects of cholesterol and polyethylene glycol derivatives.
    Moribe K; Maruyama K; Iwatsuru M
    Int J Pharm; 1999 Oct; 188(2):193-202. PubMed ID: 10518675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular localization and state of amphotericin B in PEG liposomes.
    Moribe K; Maruyama K; Iwatsuru M
    Int J Pharm; 1999 Dec; 193(1):97-106. PubMed ID: 10581426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmaceutical design of the liposomal antimicrobial agents for infectious disease.
    Moribe K; Maruyama K
    Curr Pharm Des; 2002; 8(6):441-54. PubMed ID: 12069381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spectroscopic investigation of the molecular state of nystatin encapsulated in liposomes.
    Moribe K; Maruyama K; Iwatsuru M
    Int J Pharm; 2000 May; 201(1):37-49. PubMed ID: 10867263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The study on brain targeting of the amphotericin B liposomes.
    Zhang X; Xie J; Li S; Wang X; Hou X
    J Drug Target; 2003 Feb; 11(2):117-22. PubMed ID: 12881198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of cholesterol on the release of amphotericin B from PEG-phospholipid micelles.
    Vakil R; Kwon GS
    Mol Pharm; 2008; 5(1):98-104. PubMed ID: 18159926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of poly(ethylene glycol) (PEG) concentration on the permeability of PEG-grafted liposomes.
    Hashizaki K; Taguchi H; Itoh C; Sakai H; Abe M; Saito Y; Ogawa N
    Chem Pharm Bull (Tokyo); 2005 Jan; 53(1):27-31. PubMed ID: 15635224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
    Hadinoto K; Sundaresan A; Cheow WS
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carboxyfluorescein leakage from poly(ethylene glycol)-grafted liposomes induced by the interaction with serum.
    Hashizaki K; Taguchi H; Sakai H; Abe M; Saito Y; Ogawa N
    Chem Pharm Bull (Tokyo); 2006 Jan; 54(1):80-4. PubMed ID: 16394554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reformulation of Fungizone by PEG-DSPE Micelles: Deaggregation and Detoxification of Amphotericin B.
    Alvarez C; Shin DH; Kwon GS
    Pharm Res; 2016 Sep; 33(9):2098-106. PubMed ID: 27198671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination antifungal therapy involving amphotericin B, rapamycin and 5-fluorocytosine using PEG-phospholipid micelles.
    Vakil R; Knilans K; Andes D; Kwon GS
    Pharm Res; 2008 Sep; 25(9):2056-64. PubMed ID: 18415047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ascorbyl dipalmitate/PEG-lipid nanoparticles as a novel carrier for hydrophobic drugs.
    Moribe K; Maruyama S; Inoue Y; Suzuki T; Fukami T; Tomono K; Higashi K; Tozuka Y; Yamamoto K
    Int J Pharm; 2010 Mar; 387(1-2):236-43. PubMed ID: 20005934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimation of surface state of poly(ethylene glycol)-coated liposomes using an aqueous two-phase partitioning technique.
    Moribe K; Maruyama K; Iwatsuru M
    Chem Pharm Bull (Tokyo); 1997 Oct; 45(10):1683-7. PubMed ID: 9353897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged blood circulation of methotrexate by modulation of liposomal composition.
    Hong MS; Lim SJ; Lee MK; Kim YB; Kim CK
    Drug Deliv; 2001; 8(4):231-7. PubMed ID: 11757781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of surfactants on the in vitro and in vivo properties of amphotericin B liposome].
    Zhang XB; Xie JQ; Hou XP
    Yao Xue Xue Bao; 2003 Jun; 38(6):471-4. PubMed ID: 14513812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization of the hydrophobic domain in poly(ethylene oxide)-poly(varepsilon-caprolactone) based nano-carriers for the solubilization and delivery of Amphotericin B.
    Falamarzian A; Lavasanifar A
    Colloids Surf B Biointerfaces; 2010 Nov; 81(1):313-20. PubMed ID: 20674292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poly(ethylene glycol)-modification of the phospholipid vesicles by using the spontaneous incorporation of poly(ethylene glycol)-lipid into the vesicles.
    Sou K; Endo T; Takeoka S; Tsuchida E
    Bioconjug Chem; 2000; 11(3):372-9. PubMed ID: 10821653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of poly(ethylene glycol) grafting density and polymer length on liposomes: relating plasma circulation lifetimes to protein binding.
    Dos Santos N; Allen C; Doppen AM; Anantha M; Cox KA; Gallagher RC; Karlsson G; Edwards K; Kenner G; Samuels L; Webb MS; Bally MB
    Biochim Biophys Acta; 2007 Jun; 1768(6):1367-77. PubMed ID: 17400180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of different hydrophobic anchors conjugated to poly(ethylene glycol): effects on the pharmacokinetics of liposomal vincristine.
    Webb MS; Saxon D; Wong FM; Lim HJ; Wang Z; Bally MB; Choi LS; Cullis PR; Mayer LD
    Biochim Biophys Acta; 1998 Jul; 1372(2):272-82. PubMed ID: 9675310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.